GLEN BURNIE, Md. -- Cyto Pulse Sciences, a leading producer of electric field based, intradermal DNA Vaccine delivery systems, today announced approval by Swedish regulatory authorities to begin a Phase I/II study of DNA vaccination in patients with recurring prostate cancer. The trial will investigate the safety of a xenogenic...
Findings Confirm Potency of Poly-ICR as Vaccine Adjuvant SAN DIEGO, Oct. 8 /PRNewswire-FirstCall/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN) today presented positive data from preclinical studies using its proprietary Toll-like Receptor 3 agonist, Poly IC-Poly Arginine (Poly-ICR), at the World Vaccine Congress 2008 in Lyon, France. Study...
Highlights Potential Ability of a Live Listeria Monocytogenes Vaccine to Reduce/Eliminate Tumors in Many Different Cancer Types and Prevent Reoccurrence Using Immunological Methods Collaboration Team Comprised of Advaxis' Scientific Founder, And Investigators From The University Of Pennsylvania And The Hilman Cancer Center In Pittsburgh NORTH BRUNSWICK, N.J. --...
Presentations to Address Challenges Facing Biotech Companies and the use of Bacterial Vectors for The Treatment of Cancer Conference to be Held October 6-9, 2008, at Le Palais des Congres de Lyon, France NEW BRUNSWICK, N.J. -- Advaxis Incorporated (OTCBB: ADXS) Chairman and CEO Tom Moore will present...
New Contract Extends USG's Commitment to Purchase BioThrax Through 3Q 2011 and is a Follow-on to the Existing 2007, $448 Million Contract ROCKVILLE, Md. -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has signed a new, multi-year, firm fixed price contract with the U.S. Department of Health and...
--AV7909 Contract is in Addition to Recently Announced $24 Million Development Contract for Anthrax Monoclonal and Pending Proposal to Supply HHS with Up to 25 Million Doses of a Recombinant Anthrax Vaccine ROCKVILLE, Md. -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has signed a contract with BARDA/NIAID,...
ANNAPOLIS, Md., Sept. 18 /PRNewswire-FirstCall/ -- PharmAthene, Inc. , a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company will present two poster presentations and an oral presentation on its ProtexiaR and ValortimR medical countermeasures programs at the upcoming HHS Public Health Emergency...
LONDON AFP — Schoolgirls in Scotland became the first in the country to get a jab against cervical cancer on Monday. Pupils aged 12 and 13 in several areas are being offered the vaccine from this week, as part of a nationwide programme announced last October. The programme...
Bay Bridge traffic alert! The Maryland Transportation Authority said it has closed a lane of the Chesapeake Bay Bridge to install safety measures following a fatal accident earlier this month. The closure of the right lane of the eastbound span will remain in effect for the next two...
SYDNEY AFP — Australian child welfare authorities on Tuesday ended a legal bid to force a couple to vaccinate their six-day-old baby against hepatitis B after the family went into hiding, authorities said. The New South Wales Department of Community Services decided to drop its pursuit of the couple...
SYDNEY AFP — A couple have fled their home in Australia and gone into hiding with their two-day-old son to avoid having him forcibly vaccinated against hepatitis B, a report said on Saturday. The family, including the boy's mother who was diagnosed with hepatitis B several years ago, went...
ImmuneRegen ® BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc. (OTCBB: IRBS), today announced a collaborative relationship with the Biodesign Institute at Arizona State University ASU, Tempe, Ariz., to evaluate the effectiveness of ImmuneRegen's Viprovex ® in boosting the immune response when...
The death of government scientist Bruce Ivins, a new focus of the investigation into the 2001 anthrax attacks, revives old questions about anthrax and adds new ones. USA TODAY reporters Dan Vergano and Steve Sternberg provide a sampling: Q: What is anthrax? ...
A LEADING army microbiologist suspected of being behind the anthrax mailings in the US in autumn 2001 has apparently committed suicide, it emerged yesterday - just as federal prosecutors were preparing to bring capital charges against him for the attacks, which killed five people and infected 17 others. ...
WASHINGTON -- Federal agents were closing in, and Bruce Ivins knew it. The Army microbiologist who was working on a vaccine for anthrax poisoning was now being grilled as a suspect in the 2001 letter attacks that killed five people and sickened 17. FBI agents were staking out...
The company's submission provides the U.S. Government with the critical option to select a domestic source to meet planned procurement of 25 million doses of rPA vaccine ROCKVILLE, Md. -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has submitted a proposal in response to a request for proposal...
GAITHERSBURG, Md. -- GenVec, Inc. (Nasdaq:GNVC) announced today that the U.S. Department of Homeland Security DHS has executed the second option period under a three-year agreement with GenVec to support the development of vaccines for the prevention of foot-and-mouth disease FMD. GenVec will receive up to $6.6 million to complete...
PARIS AFP — A new kidney cancer vaccine failed in last-phase clinical trials to improve the odds of avoiding remission after tumour-removing surgery, according to a study released Friday. A team of researchers led by Christopher Wood of the Anderson Cancer Center in Houston, Texas gave the vaccine, called...
ATHENS, Ohio -- Diagnostic HYBRIDS has received funding through the Biomedical Research Commercialization Program BRCP to develop more sensitive and affordable assays for the monitoring of patients infected with Human Immunodeficiency Virus HIV and/or Hepatitis C Virus HCV and to produce vaccines against influenza virus. The BRCP is part of...
Medicago Inc. (TSX VENTURE: MDG) (the "Company"), today announced that Mr. Andy Sheldon, President and CEO, will participate in a panel discussion entitled "Addressing the limited global capacity in producing pandemic and seasonal flu vaccines" at the World Vaccine Congress Asia 2008. The conference will be held at the Grand...
Beat the crowds and save big on their favorite sports gear! Shop today
